Warner Chilcott

From Wikipedia, the free encyclopedia

 This article does not cite any references or sources. (June 2007)
Please help improve this article by adding citations to reliable sources. Unverifiable material may be challenged and removed.

Warner Chilcott (formerly Galen) is a Northern Irish pharmaceutical company. It is primarily focused on two core therapeutic areas: women’s healthcare and dermatology. The company has 930 employees in Ireland, the UK, USA and Puerto Rico.

[edit] History

In 1968 the Company was founded as Galen, a sales and marketing organisation focused on branded pharmaceutical products in the UK and Republic of Ireland. The company listed its shares on the London Stock Exchange and Irish Stock Exchange. In 2000, Galen acquired the Warner Chilcott US pharmaceutical company which is focused on women’s healthcare, and simultaneously listed its ADRs on NASDAQ. In 2004, the company changed its name from Galen to Warner Chilcott.

[edit] See also

[edit] External links

  This article about a medical, pharmaceutical or biotechnological corporation or company is a stub. You can help Wikipedia by expanding it.
 This Northern Ireland related article is a stub. You can help Wikipedia by expanding it.
 This European corporation or company article is a stub. You can help Wikipedia by expanding it.